Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 6551 - 6575 of 8039 in total
Anrukinzumab has been used in trials studying the diagnostic of Asthma.
Investigational
Matched Description: … Anrukinzumab has been used in trials studying the diagnostic of Asthma. …
Tavilermide has been investigated for the treatment of Dry Eye Syndromes.
Investigational
Matched Description: … Tavilermide has been investigated for the treatment of Dry Eye Syndromes. …
Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.
Investigational
Matched Description: … Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer. …
PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Investigational
Matched Description: … PF-00446687 has been investigated for the treatment of Erectile Dysfunction. …
Intetumumab has been used in trials studying the treatment of Melanoma.
Investigational
Matched Description: … Intetumumab has been used in trials studying the treatment of Melanoma. …
Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.
Investigational
Matched Description: … Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation. …
Get 73 has been investigated for the treatment of Alcohol Dependence.
Investigational
Matched Description: … Get 73 has been investigated for the treatment of Alcohol Dependence. …
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Matched Description: … TBD has been used in trials studying the treatment of Adenocarcinoma. …
Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.
Investigational
Matched Description: … Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis. …
Neladenoson bialanate has been investigated for the treatment of Heart Failure.
Investigational
Matched Description: … Neladenoson bialanate has been investigated for the treatment of Heart Failure. …
beta-Apopicropodophyllin is a component of the freshwater plant Micranthemum umbrosum.
Experimental
Matched Description: … beta-Apopicropodophyllin is a component of the freshwater plant _Micranthemum umbrosum_. …
PD-98059 is an inhibitor of MAP-kinase kinase activation.
Investigational
Matched Description: … PD-98059 is an inhibitor of MAP-kinase kinase activation.[A253072] …
Dilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells.
Investigational
Matched Description: … Dilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells. …
SPG601 is being investigated for the treatment of fragile X syndrome.
Investigational
Matched Description: … SPG601 is being investigated for the treatment of fragile X syndrome. …
Abivertinib is a tyrosine kinase inhibitor targeted against mutant forms of both human epidermal growth factor receptor (EGFR) and Bruton's tyrosine kinase (BTK). It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies. In binding to and inhibiting EGFR and BTK receptors,...
Investigational
Matched Description: … Abivertinib is a tyrosine kinase inhibitor targeted against mutant forms of both human epidermal growth ... [L17383] It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and ... BTK receptors, abivertinib exerts immunomodulatory effects by preventing the production and release of
Toluene is a colorless, liquid that is immiscible in water. It is a mono-substituted benzene derivative used in veterinary medicine as a treatment for various parasites in dogs and cats.
Vet approved
The RUTI® Vaccine contains fragmented, purified and liposomed heat-inactivated Mycobacterium tuberculosis bacilli. The vaccine has demonstrated a reasonable safety profile and potent stimulation of the immune response against tuberculosis. Much like the BCG vaccine, the RUTI® vaccine is also being tested as a prophylactic for SARS-CoV2. Sponsored by Fundació Institut...
Investigational
Matched Description: … The vaccine has demonstrated a reasonable safety profile and potent stimulation of the immune response ... Sponsored by Fundació Institut Germans Trias i Pujol, the RUTI® Vaccine is being tested for prevention of
A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES. [PubChem]
Experimental
Matched Description: … It is a coenzyme of some DEHYDROGENASES. [PubChem] …
5'-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS.
Experimental
Investigational
Matched Description: … The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. …
Allosamidin exhibits extremely potent inhibitory activity against chitinases from a number of sources, particularly from Candida albicans, and can be utilized as potent antifungal agent.
Experimental
Matched Description: … Allosamidin exhibits extremely potent inhibitory activity against chitinases from a number of sources …
NGX267 is a muscarinic agonist. It is developed for the treatment of Alzheimer’s disease and has shown the potential to both reduce symptoms and slow disease progression.
Investigational
Matched Description: … It is developed for the treatment of Alzheimer’s disease and has shown the potential to both reduce symptoms …
AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. It is developed by AstraZeneca and is currently in phase I/II trials.
Investigational
Matched Description: … AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. …
Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
Investigational
Matched Description: … Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis …
AVI-4020 is a neugene antisense drug candidate for the treatment of patients with acute West Nile virus disease who have serious neurological impairment (WNV neuroinvasive disease).
Investigational
Matched Description: … AVI-4020 is a neugene antisense drug candidate for the treatment of patients with acute West Nile virus …
Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects).
Investigational
Matched Description: … investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of
Displaying drugs 6551 - 6575 of 8039 in total